Tenax Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
90.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-2.10
|
-2.20
|
-0.10
|
-4.76%
|
|
2022-06-30
|
-1.80
|
-2.20
|
-0.40
|
-22.22%
|
|
2022-03-31
|
-0.09
|
-0.11
|
-0.02
|
-22.22%
|
|
2021-12-31
|
-3.20
|
-0.80
|
2.40
|
75.00%
|
|
2021-09-30
|
-2.60
|
-3.00
|
-0.40
|
-15.38%
|
|
2021-06-30
|
-2.60
|
-2.00
|
0.60
|
23.08%
|
|
2021-03-31
|
-4.20
|
-32.80
|
-28.60
|
-680.95%
|
|
2020-12-31
|
-2.80
|
-12.00
|
-9.20
|
-328.57%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.51
|
|
2021-12-31
|
-38.60
|
|
2020-12-31
|
-12.79
|
|
2019-12-31
|
-1.35
|
|
2018-12-31
|
-4.12
|
|
2017-12-31
|
-6.35
|
|
2016-12-31
|
-7.60
|
|
2015-12-31
|
-5.04
|
|
2014-12-31
|
-16.14
|
|
2013-12-31
|
-109.88
|
|
2012-12-31
|
-225.44
|
|
2011-12-31
|
-360.81
|
|
2010-12-31
|
-188.82
|
|
2009-12-31
|
-672.39
|
|
2008-12-31
|
-746.62
|
|
2007-12-31
|
-206.41
|
|
2006-12-31
|
-141.89
|
|
2005-12-31
|
-186.38
|
|
2004-12-31
|
-130.26
|
|
2003-12-31
|
-133.63
|
|
2002-12-31
|
-261.73
|
|
2001-12-31
|
-139.07
|
|
2000-12-31
|
-81.62
|